High serum enalaprilat in chronic renal failure
Background Most angiotensin-converting enzyme (ACE) inhibitors and their metabolites are excreted renally and doses should hence be reduced in renal insufficiency. We studied whether the dosage of enalapril in daily clinical practice is associated with drug accumulation of enalaprilat in chronic ren...
Main Authors: | Thomas Elung-Jensen, Jens Heisterberg, Anne-Lise Kamper, Jesper Sonne, Svend Strandgaard, Niels Erik Larsen |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publications
2001-12-01
|
Series: | Journal of the Renin-Angiotensin-Aldosterone System |
Online Access: | https://doi.org/10.3317/jraas.2001.038 |
Similar Items
-
Completing the Enalaprilat Excretion Pathway—Renal Handling by the Proximal Tubule
by: Nori J. L. Smeets, et al.
Published: (2020-09-01) -
Renal graft failure after addition of an angiotensin II receptor antagonist to an angiotensin-converting enzyme inhibitor: unmasking of an unknown iliac artery stenosis
by: Anne-Lise Kamper, et al.
Published: (2002-06-01) -
EXPRESS METHOD FOR DETERMINATION OF ENALAPRIL AND ENALAPRILAT IN HUMAN SERUM BY HPLC-MS/MS
by: T. A. Rodina, et al.
Published: (2019-01-01) -
Objectively measured medication adherence using assays for carvedilol and enalaprilat in patients with heart failure in Mozambique and Nigeria
by: Julius Chacha Mwita, et al.
Published: (2023-12-01) -
Enalapril and Enalaprilat Pharmacokinetics in Children with Heart Failure Due to Dilated Cardiomyopathy and Congestive Heart Failure after Administration of an Orodispersible Enalapril Minitablet (LENA-Studies)
by: Stephanie Laeer, et al.
Published: (2022-05-01)